# Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

> **NCT00857480** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 12 (actual)

## Conditions studied

- Hepatic Cirrhosis

## Interventions

- **DRUG:** NRL972
- **DRUG:** NRL972
- **DRUG:** NRL972

## Key facts

- **NCT ID:** NCT00857480
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-08
- **Final completion:** 2006-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2009-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857480, "Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00857480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*